Bajaj Healthcare growth over the years

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+12.6%−3.2%
EBITDA+27.2%−0.6%
Net Income−60.1%−28.4%
EPS (adj.)−60.1%−28.4%
Total Assets+10.8%+0.8%
Total Equity+14.3%+13.2%
Free Cash Flow+46.2%—
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

BAJAJHCARE₹314.45

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,059 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+12.6-3.2
EBITDA+27.2-0.6
Net Income-60.1-28.4
EPS (adj.)-60.1-28.4
Total Assets+10.8+0.8
Total Equity+14.3+13.2
Free Cash Flow+46.2—
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.